MYC and thyroid cancer: qRT-PCR results showed that while LINC00162 inhibition (****p < 0.0001) and treatment with sorafenib (****p < 0.0001) reduced MYC expression in B-CPAP thyroid cancer cells, combination of these therapeutic methods significantly reduced of MYC expression compared to control (****p < 0.0001) and individual groups (****p < 0.0001).